TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL GENOMICS MARKET, BY APPLICATION & TECHNOLOGY
6.1. Overview
6.2. Functional Genomics
6.3. Epigenomics
6.4. Pathway Analysis
6.5. Biomarker Discovery
7. GLOBAL GENOMICS MARKET, BY END-USE
7.1. Overview
7.2. Clinical Research
7.3. Academic & Government Institutes
7.4. Hospitals & Clinics
7.5. Pharmaceutical & Biotechnology Companies
7.6. Other End Users
8. GLOBAL GENOMICS MARKET, BY DELIVERABLES
8.1. Overview
8.2. Products
8.3. Services
9. GLOBAL GENOMICS MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Genomics Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Genomics Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. COMPANY PROFILES
11.1. AGILENT TECHNOLOGIES
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Bio-Rad Laboratories, Inc.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. BGI Genomics
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Color Genomics, Inc.
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Danaher Corporation
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Eppendorf AG
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Eurofins Scientific
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. F. Hoffmann-La Roche Ltd.
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. GE Healthcare
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Illumina, Inc.
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Myriad Genetics, Inc.
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Products Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Oxford Nanopore Technologies
11.12.1. Company Overview
11.12.2. Financial Overview
11.12.3. Products Offered
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
11.13. Pacific Biosciences of California, Inc.
11.13.1. Company Overview
11.13.2. Financial Overview
11.13.3. Products Offered
11.13.4. Key Developments
11.13.5. SWOT Analysis
11.13.6. Key Strategies
11.14. QIAGEN N.V.
11.14.1. Company Overview
11.14.2. Financial Overview
11.14.3. Products Offered
11.14.4. Key Developments
11.14.5. SWOT Analysis
11.14.6. Key Strategies
11.15. Quest Diagnostics Incorporated
11.15.1. Company Overview
11.15.2. Financial Overview
11.15.3. Products Offered
11.15.4. Key Developments
11.15.5. SWOT Analysis
11.15.6. Key Strategies
11.16. Thermo Fisher Scientific, Inc.
11.16.1. Company Overview
11.16.2. Financial Overview
11.16.3. Products Offered
11.16.4. Key Developments
11.16.5. SWOT Analysis
11.16.6. Key Strategies
11.17. 23andMe, Inc.
11.17.1. Company Overview
11.17.2. Financial Overview
11.17.3. Products Offered
11.17.4. Key Developments
11.17.5. SWOT Analysis
11.17.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL GENOMICS MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL GENOMICS MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 9 US: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 10 US: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 11 US: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 12 CANADA: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 13 CANADA: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 14 CANADA: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 3 EUROPE: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 4 GERMANY: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 5 GERMANY: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 6 GERMANY: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 7 FRANCE: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 8 FRANCE: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 9 FRANCE: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 10 ITALY: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 11 ITALY: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 12 ITALY: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 13 SPAIN: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 14 SPAIN: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 15 SPAIN: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 16 UK: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 17 UK: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 18 UK: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 25 JAPAN: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 26 JAPAN: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 27 JAPAN: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 28 CHINA: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 29 CHINA: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 30 CHINA: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 31 INDIA: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 32 INDIA: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 33 INDIA: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 34 AUSTRALIA: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 35 AUSTRALIA: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 36 AUSTRALIA: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 49 AFRICA: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 50 AFRICA: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 51 AFRICA: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION & TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: GENOMICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: GENOMICS MARKET, BY DELIVERABLES, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL GENOMICS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL GENOMICS MARKET
FIGURE 4 GLOBAL GENOMICS MARKET, SHARE (%), BY APPLICATION & TECHNOLOGY, 2021
FIGURE 5 GLOBAL GENOMICS MARKET, SHARE (%), BY END-USE, 2021
FIGURE 6 GLOBAL GENOMICS MARKET, SHARE (%), BY DELIVERABLES, 2021
FIGURE 7 GLOBAL GENOMICS MARKET, SHARE (%), BY REGION, 2021
FIGURE 8 NORTH AMERICA: GENOMICS MARKET, SHARE (%), BY REGION, 2021
FIGURE 9 EUROPE: GENOMICS MARKET, SHARE (%), BY REGION, 2021
FIGURE 10 ASIA-PACIFIC: GENOMICS MARKET, SHARE (%), BY REGION, 2021
FIGURE 11 REST OF THE WORLD: GENOMICS MARKET, SHARE (%), BY REGION, 2021
FIGURE 12 GLOBAL GENOMICS MARKET: COMPANY SHARE ANALYSIS, 2021 (%)
FIGURE 13 AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 AGILENT TECHNOLOGIES: SWOT ANALYSIS
FIGURE 15 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS
FIGURE 17 BGI GENOMICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 BGI GENOMICS: SWOT ANALYSIS
FIGURE 19 COLOR GENOMICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 COLOR GENOMICS, INC.: SWOT ANALYSIS
FIGURE 21 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 DANAHER CORPORATION: SWOT ANALYSIS
FIGURE 23 EPPENDORF AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 EPPENDORF AG: SWOT ANALYSIS
FIGURE 25 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 EUROFINS SCIENTIFIC: SWOT ANALYSIS
FIGURE 27 F. HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS
FIGURE 29 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 GE HEALTHCARE: SWOT ANALYSIS
FIGURE 31 ILLUMINA, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 ILLUMINA, INC.: SWOT ANALYSIS
FIGURE 33 MYRIAD GENETICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 MYRIAD GENETICS, INC.: SWOT ANALYSIS
FIGURE 35 OXFORD NANOPORE TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 OXFORD NANOPORE TECHNOLOGIES: SWOT ANALYSIS
FIGURE 37 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: SWOT ANALYSIS
FIGURE 39 QIAGEN N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 QIAGEN N.V.: SWOT ANALYSIS
FIGURE 41 QUEST DIAGNOSTICS INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 QUEST DIAGNOSTICS INCORPORATED: SWOT ANALYSIS
FIGURE 43 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 44 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
FIGURE 45 23ANDME, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 46 23ANDME, INC.: SWOT ANALYSIS
